A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies.
Saved in:
| Title: | A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies. |
|---|---|
| Authors: | Piha-Paul, Sarina A (AUTHOR), Dumbrava, Ecaterina E (AUTHOR), Nair, Binoj C (AUTHOR), Xiong, Wendy (AUTHOR), Xu, Li (AUTHOR), Mostorino, Rosa (AUTHOR), Subbiah, Vivek (AUTHOR), Tannir, Nizar (AUTHOR), Fu, Siqing (AUTHOR), Naing, Aung (AUTHOR), Janku, Filip (AUTHOR), Karp, Daniel D (AUTHOR), Patel, Shreyaskumar (AUTHOR), Daw, Najat C (AUTHOR), Hong, David (AUTHOR), Meric-Bernstam, Funda (AUTHOR), Zinner, Ralph (AUTHOR) |
| Source: | OncoTargets & Therapy. May2021, Vol. 14, p3037-3049. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11786930 |
|---|---|
| DOI: | 10.2147/OTT.S291801 |
